Science and Research Overview

Singapore's science and research system is a national capability-building and translation system, not a single research institution. The National Research Foundation (NRF) coordinates the national Research, Innovation and Enterprise (RIE) strategy and funding direction; A*STAR is the lead public-sector R&D agency; universities, hospitals, companies and international partners perform or support research across the wider ecosystem. The system links basic research, talent, infrastructure, applied work and commercialisation, while the separate rd statistics topic measures R&D expenditure rather than the size of an RIE funding envelope (NRF, accessed September 2026; A*STAR, accessed September 2026).

National strategy and the RIE2030 planning cycle

Singapore organises national research priorities through successive five-year RIE plans. The RIE2030 plan covers the five years from April 2026 and commits S$37 billion to research, innovation and enterprise; the commitment is a plan-level public investment envelope, not Singapore's annual GERD and not a grant that every researcher or company receives automatically (NRF RIE2030, updated 4 June 2026; NRF RIE2030 press release, 5 December 2025).

RIE2030 combines long-term investment in basic research, talent and infrastructure with a stronger focus on translation and national or economic priorities. Its new large-scale instruments include two RIE Flagships and two RIE Grand Challenges, alongside strengthened capabilities in AI, data and compute. These instruments are strategic programmes within the national plan; they should not be collapsed into the separate grant schemes, fellowships, university funds or company-support programmes described in child topics such as research policy and funding and ai for science (NRF RIE2030, updated 4 June 2026).

Agencies, universities and translation roles

The NRF sets national RIE direction and supports the ecosystem through strategy, major programmes, talent instruments and research infrastructure planning. A*STAR conducts mission-oriented, economic-oriented public research through biomedical sciences and physical sciences and engineering institutes, and acts as a bridge between academia and industry. Universities remain major performers of basic and academic research, educate researchers and host research centres and collaborations; the university research ecosystem topic covers those university-specific structures (NRF, accessed September 2026; A*STAR Research, accessed September 2026; A*STAR, accessed September 2026).

Translation does not mean that every publicly funded project becomes a product or that ASTAR replaces the universities. ASTAR describes partnerships with public and private-sector organisations, support for local enterprises and R&D-driven start-ups, and outcomes spanning economic growth, healthcare, urban living and sustainability. The appropriate institution therefore depends on the question: NRF for national strategy and instruments, A*STAR for public-sector research institutes and translation, universities for academic research and training, and the relevant agency or company for a specific programme or application (A*STAR, accessed September 2026).

Research fields, infrastructure and evidence boundaries

Singapore's public research capabilities span biomedical sciences and physical sciences and engineering, with research entities concentrated especially around Biopolis and Fusionopolis. Current national emphasis also includes AI, data and compute, while individual programmes cover areas such as quantum technologies, RNA biology, aquaculture, space and advanced manufacturing. A field appearing in RIE2030 or an A*STAR portfolio is evidence of strategic or institutional scope; it is not by itself evidence that Singapore leads the field globally or that a particular technology is deployed at national scale (NRF RIE2030, updated 4 June 2026; A*STAR Research, accessed September 2026).

R&D statistics require their own denominator and period. GERD, BERD and public-sector R&D expenditure describe measured spending for a reference year, whereas RIE2030 describes a forward-looking multi-year policy envelope; neither should be substituted for the other. Questions about a current research centre, grant call, award, dataset or laboratory should be answered from the administering institution's current source and linked to the appropriate child topic rather than inferred from this overview (NRF, accessed September 2026).